Jan 14 (Reuters) - Structure Therapeutics' (GPCR.O), opens new tab CEO expects oral weight-loss pills to capture as much as half of the GLP-1 market by 2030, driven partly by pent-up demand from ...
Obesity stocks slump on Novo's underwhelming 2026 sales forecast Shares of obesity drugmakers and developers slid on Tuesday, after Novo Nordisk forecast a sharper-than-expected sales decline for 2026 ...
Machine learning is the ability of a machine to improve its performance based on previous results. Machine learning methods enable computers to learn without being explicitly programmed and have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results